SCHEMBL23382695

SCHEMBL23382695

CC(C)(Oc1ccc(C(=O)OCC(F)(F)C(=O)O)cc1)c1ccccc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPK1 P28482 1/20 0.44
▸ HIF1A Q16665 1/20 0.44
▸ SMN1; SMN2 Q16637 4/20 0.43
▸ TP53 P04637 1/20 0.43
▸ HPGD P15428 1/20 0.43
▸ TDP1 Q9NUW8 4/20 0.41
▸ HTR1A P08908 1/20 0.41
▸ CYP2D6 P10635 1/20 0.41
▸ SCN1A P35498 1/20 0.41
▸ SLC6A3 Q01959 1/20 0.41
▸ SCN5A Q14524 1/20 0.41
▸ SCN2A Q99250 1/20 0.41
▸ SCN3A Q9NY46 1/20 0.41
▸ MAPT P10636 4/20 0.40
▸ L3MBTL1 Q9Y468 1/20 0.40
▸ ALDH1A1 P00352 1/20 0.39
▸ KMT2A Q03164 1/20 0.39
▸ RAB9A P51151 4/20 0.39
▸ NPC1 O15118 3/20 0.39
▸ PPARA Q07869 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23382799 0.85 TDP1 (0.42) MAPK1HIF1ASMN1; SMN2TP53HPGD
SCHEMBL23382690 0.85 TP53 (0.47) MAPK1HIF1ASMN1; SMN2TP53HPGD
SCHEMBL23382691 0.83 TP53 (0.45) MAPK1HIF1ASMN1; SMN2TP53HPGD
SCHEMBL23382685 0.82 SMN1; SMN2 (0.44) MAPK1HIF1ASMN1; SMN2TP53HPGD
SCHEMBL23382693 0.82 SMN1; SMN2 (0.44) MAPK1HIF1ASMN1; SMN2TP53HPGD
SCHEMBL23382688 0.81 TP53 (0.43) MAPK1HIF1ASMN1; SMN2TP53HPGD
SCHEMBL24361126 0.80 MAPK1 (0.67) MAPK1HIF1AHPGDTDP1HTR1A
SCHEMBL5706162 0.76 MAPT (0.62) SMN1; SMN2TDP1MAPTL3MBTL1ALDH1A1
SCHEMBL23382489 0.76 MAPK1 (0.45) MAPK1HIF1ASMN1; SMN2TP53HPGD
SCHEMBL23559376 0.76 RAB9A (0.51) MAPK1HIF1ASMN1; SMN2TDP1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11762287-B2 Onium salt compound, chemically amplified resist composition and patterning process SHIN-ETSU CHEMICAL CO., LTD. (JP) 2023-09-19 — — US disclosed
US-11762287-B2 Onium salt compound, chemically amplified resist composition and patterning process SHIN-ETSU CHEMICAL CO., LTD. (JP) 2023-09-19 — — US disclosed
US-20210149301-A1 ONIUM SALT COMPOUND, CHEMICALLY AMPLIFIED RESIST COMPOSITION AND PATTERNING PROCESS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2021-05-20 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11762287-B2 Onium salt compound, chemically amplified resist composition and patterning process IDUA, SLC6A5, SLC6A9 MAPK1 229/4885HIF1A 4225/4885SMN1; SMN2 3745/4885
US-20210149301-A1 ONIUM SALT COMPOUND, CHEMICALLY AMPLIFIED RESIST COMPOSITION AND PATTERNING PROCESS IDUA, SLC6A5, SLC6A9 MAPK1 229/4885HIF1A 4225/4885SMN1; SMN2 3745/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback